On the other hand, co-administration of P2X7 antagonist JNJ rather than the agonist BzATP and Atr-I raised the antitumor effect, which might be derived from the complicated microenvironment of human cervical cancer. The gene discussed is P2RX7; the disease is cervical carcinoma.